Genesis Research, LLC

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Prostate cancer3 trials
• Bladder cancer2 trials

Phase

• Phase 32 trials

Status

• Completed3 trials
• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Sumitomo Pharma America, Inc.2 trials
• Convergent Genomics, Inc.1 trial
• Genesis Research LLC1 trial
• UroGen Pharma Ltd.1 trial

Running trials

• Recruiting

  Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

  NCT07673016· Convergent Genomics, Inc.· Source

Closed trials

• Completed

  A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer

  NCT06331299· Phase 3· UroGen Pharma Ltd.· Source

• Terminated

  Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging

  NCT05826470· Genesis Research LLC· Source

• Completed

  Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate

  NCT05605964· Phase 3· Sumitomo Pharma America, Inc.· Source

• Completed

  A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

  NCT05467176· Sumitomo Pharma America, Inc.· Source